ClinicalTrials.Veeva

Menu

Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging (RECTOMICS)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Rectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04920435
RECTOMICS (29BRC20.0027)

Details and patient eligibility

About

In patient with complete pathological response, surgery could be omitted without compromising progression-free or overall survival. A powerful prediction model is needed to guide management of this population.

Radiomics features provide complementary information about tumor heterogenity.

The aim of the investigators is to develop a model combining clinical and radiomic criteria able to predict complete pathological response.

Enrollment

124 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • locally advanced rectal cancer
  • patients who received concomitant radio-chemotherapy followed by surgery
  • pre-therapeutic MRI and CT-scan dicom available

Exclusion criteria

  • age under 18 yo
  • lack of MRI or CT-scan

Trial design

124 participants in 2 patient groups

training population
Description:
patients from which we will develop the prediction model
testing population
Description:
patients on whom we will test the prediction model

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems